Cargando…

Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score

PURPOSE: To construct and validate a combined nomogram model based on magnetic resonance imaging (MRI) radiomics and Albumin-Bilirubin (ALBI) score to predict therapeutic response in unresectable hepatocellular carcinoma (HCC) patients treated with hepatic arterial infusion chemotherapy (HAIC). METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yang, Huang, Fang, Liu, Siye, Jian, Lian, Xia, Xibin, Lin, Huashan, Liu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349720/ https://www.ncbi.nlm.nih.gov/pubmed/36369395 http://dx.doi.org/10.1007/s00432-022-04467-3

Ejemplares similares

Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy
por: Wu, Tianqing, et al.
Publicado: (2023)

Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Albumin-bilirubin score: an additional tool for the management of patients with hepatocellular carcinoma
por: Serenari, Matteo, et al.
Publicado: (2020)

To determine the prognostic value of the albumin–bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Khalid, Muhammad Ali, et al.
Publicado: (2019)

On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Wang, Hung-Wei, et al.
Publicado: (2021)

Hepatic Arterial Infusion Chemotherapy for Patients with Huge Unresectable Hepatocellular Carcinoma
por: Tsai, Wei-Lun, et al.
Publicado: (2014)

Pretherapeutic Serum Albumin as an Outcome Prognosticator in Head and Neck Adenoid-Cystic Carcinoma
por: Friedl, Marlene, et al.
Publicado: (2022)

Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
por: Zhou, Xuezhi, et al.
Publicado: (2019)

Predicting Survival for Hepatic Arterial Infusion Chemotherapy of Unresectable Colorectal Liver Metastases: Radiomics Analysis of Pretreatment Computed Tomography
por: Liu, Peng, et al.
Publicado: (2022)

A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma
por: Ho, Shu-Yein, et al.
Publicado: (2022)

Predictive Power of the Albumin–Bilirubin Score for Hepatotoxicity in Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma
por: Joo, Jihyeon, et al.
Publicado: (2023)

Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study
por: Lee, Jaejun, et al.
Publicado: (2021)

Perioperative and prognostic implication of albumin‐bilirubin‐TNM score in Child‐Pugh class A hepatocellular carcinoma
por: Sonohara, Fuminori, et al.
Publicado: (2018)

Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization
por: Antkowiak, Mark, et al.
Publicado: (2019)

Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma
por: Elshaarawy, Omar, et al.
Publicado: (2019)

Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Liu, Baojiang, et al.
Publicado: (2019)

Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study
por: Kim, Ji Hoon, et al.
Publicado: (2023)

Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy
por: Kaibori, Masaki, et al.
Publicado: (2022)

The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma
por: Ruzzenente, Andrea, et al.
Publicado: (2019)

The Application Value of MRI T2(∗)WI Radiomics Nomogram in Discriminating Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma
por: Huang, Feng, et al.
Publicado: (2022)

The prognostic and predictive value of the albumin-bilirubin score in advanced pancreatic cancer
por: Zhang, Tie-Ning, et al.
Publicado: (2020)

Albumin-Bilirubin Score: A Novel Mortality Predictor in Valvular Surgery
por: Duman, Zihni Mert, et al.
Publicado: (2023)

Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study
por: Lee, Soon Kyu, et al.
Publicado: (2019)

Abnormal Serum Bilirubin/Albumin Concentrations in Dementia Patients With Aβ Deposition and the Benefit of Intravenous Albumin Infusion for Alzheimer’s Disease Treatment
por: Zhong, Xiaomei, et al.
Publicado: (2020)

Efficacy and safety of hepatic arterial infusion chemotherapy combined with transarterial embolization for unresectable hepatocellular carcinoma: A propensity score‐matching cohort study
por: Guo, Wenbo, et al.
Publicado: (2019)

Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma
por: Tsai, Wei-Lun, et al.
Publicado: (2020)

Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases
por: Feng, Dayun, et al.
Publicado: (2020)

Assessment of the albumin-bilirubin score in breast cancer patients with liver metastasis after surgery()
por: Chen, Li, et al.
Publicado: (2023)

Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child–Pugh A patients treated with radical surgery: A retrospective observational study
por: Wu, Binquan, et al.
Publicado: (2019)

Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis
por: Dong, Zhao-Ru, et al.
Publicado: (2017)

Effectiveness of the albumin-bilirubin score as a prognostic factor for early recurrence after curative hepatic resection for hepatocellular carcinoma
por: Lee, Yun Ho, et al.
Publicado: (2018)

Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma
por: Wang, Zhexuan, et al.
Publicado: (2020)

Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade
por: Ho, Shu-Yein, et al.
Publicado: (2020)

Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT)
por: Ho, Connie H.M., et al.
Publicado: (2018)

Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation
por: Ma, Tao, et al.
Publicado: (2019)

Clinical Significance of Combining Preoperative and Postoperative Albumin-Bilirubin Score in Colorectal Cancer
por: Kim, Doyoun, et al.
Publicado: (2023)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Bilirubin/Albumin Ratio for Predicting Acute Bilirubin-induced Neurologic Dysfunction
por: Ardakani, Shahin Behjati, et al.
Publicado: (2011)

Pretreatment Modified Albumin–Bilirubin Grade Is an Important Predictive Factor Associated with the Therapeutic Response and the Continuation of Atezolizumab plus Bevacizumab Combination Therapy for Patients with Unresectable Hepatocellular Carcinoma
por: Tanaka, Takashi, et al.
Publicado: (2022)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7vb96oalpo2ef5gmr3gl773scf